Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype

• Main Authors: C. Riccay Elizondo (Author), Jennifer D. Bright (Author), Robert K. Bright (Author)
• פורמט: ספר
• יצא לאור: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Cancer immunotherapy is a powerful tool for inducing antigen-specific antitumor cytotoxic T lymphocytes (CTLs). Next-generation strategies may include vaccination against overexpressed oncogenic tumor-self antigens. Previously, we reported vaccination against the oncogenic tumor-self antigen D52 (D5...